This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
To the Editor:—
The article on the use of propylthiouracil in thyrotoxicosis by Dr. William S. Reveno (The Journal, April 19, p. 1190) presented some unusual if not distressing data. Of 18 previously untreated cases, 9 were reported with initial basal metabolic rates ranging from plus 9 to plus 15 inclusive. While I am not unaware that thyrotoxicosis may occur with a metabolic rate near plus 15, such an occurrence is decidedly uncommon and should be supported by carefully documented observations. I believe the use of so potent and revolutionary a drug as propylthiouracil certainly demands more care in the selection of cases to be reported.
Feibush JS. PROPYLTHIOURACIL IN THYROTOXICOSIS. JAMA. 1947;134(6):555. doi:10.1001/jama.1947.02880230065022
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: